N. Moreau

516 total citations
11 papers, 449 citations indexed

About

N. Moreau is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, N. Moreau has authored 11 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Medicine, 7 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in N. Moreau's work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Cancer therapeutics and mechanisms (4 papers). N. Moreau is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Cancer therapeutics and mechanisms (4 papers). N. Moreau collaborates with scholars based in France and Morocco. N. Moreau's co-authors include Marie-Dominique Kitzis, Ludwig Gutmann, E. Collatz, R. Williamson, F. W. Goldstein, J. F. Acar, Claire Janoir, Valérie Zeller, M. ESSIZ and D. Bouzard and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

N. Moreau

11 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Moreau France 8 284 192 174 120 89 11 449
M. Michéa-Hamzehpour Switzerland 10 335 1.2× 216 1.1× 214 1.2× 106 0.9× 74 0.8× 18 554
A J Godfrey Canada 14 232 0.8× 126 0.7× 186 1.1× 91 0.8× 52 0.6× 17 443
Kiyomi Okamoto Japan 7 291 1.0× 112 0.6× 166 1.0× 71 0.6× 42 0.5× 8 381
A Yotsuji Japan 11 315 1.1× 220 1.1× 130 0.7× 65 0.5× 87 1.0× 20 472
B Kolek United States 13 294 1.0× 307 1.6× 151 0.9× 206 1.7× 173 1.9× 16 637
L. D. Sabath United States 12 351 1.2× 243 1.3× 232 1.3× 97 0.8× 166 1.9× 13 620
Kristen N. Schurek Canada 10 251 0.9× 148 0.8× 183 1.1× 142 1.2× 50 0.6× 10 457
Martin S. Linsell United States 11 218 0.8× 193 1.0× 254 1.5× 82 0.7× 136 1.5× 11 594
Patrick Plésiat France 8 355 1.3× 150 0.8× 232 1.3× 84 0.7× 60 0.7× 12 548
KEIICHI SHIMIZU Switzerland 2 232 0.8× 84 0.4× 87 0.5× 53 0.4× 63 0.7× 5 301

Countries citing papers authored by N. Moreau

Since Specialization
Citations

This map shows the geographic impact of N. Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Moreau more than expected).

Fields of papers citing papers by N. Moreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Moreau. The network helps show where N. Moreau may publish in the future.

Co-authorship network of co-authors of N. Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of N. Moreau. A scholar is included among the top collaborators of N. Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Moreau. N. Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zeller, Valérie, Claire Janoir, Marie-Dominique Kitzis, Ludwig Gutmann, & N. Moreau. (1997). Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 41(9). 1973–1978. 97 indexed citations
2.
Moreau, N., et al.. (1996). Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones. Journal of Antimicrobial Chemotherapy. 38(6). 1079–1083. 6 indexed citations
3.
Thabaut, A, et al.. (1994). [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].. PubMed. 42(5). 369–74. 4 indexed citations
4.
5.
Desnottes, J. F., et al.. (1993). Influence of sub-inhibitory concentrations of antibacterials on the surface properties and adhesion of Escherichia coil. Journal of Antimicrobial Chemotherapy. 31(1). 37–45. 15 indexed citations
6.
Moreau, N., et al.. (1992). Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones. Antimicrobial Agents and Chemotherapy. 36(12). 2622–2627. 69 indexed citations
7.
Desnottes, J. F., et al.. (1990). Effect of pefloxacin on microorganism: host cell interaction. Journal of Antimicrobial Chemotherapy. 26(suppl B). 17–26. 13 indexed citations
8.
Gutmann, Ludwig, R. Williamson, N. Moreau, et al.. (1985). Cross-Resistance to Nalidixic Acid, Trimethoprim, and Chloramphenicol Associated with Alterations in Outer Membrane Proteins of Klebsiella, Enterobacter, and Serratia. The Journal of Infectious Diseases. 151(3). 501–507. 164 indexed citations
9.
Moreau, N., et al.. (1978). Are some aminoglycoside antibiotics inactivating enzymes polyfunctional?. PubMed. 128B(4). 465–9. 8 indexed citations
10.
Moreau, N., et al.. (1977). [Plasmidic resistance of "Haemophilus sp." to aminoglycoside antibiotics: isolation and study of a new phosphotransferase (author's transl)].. PubMed. 128A(4). 383–91. 4 indexed citations
11.
Goffic, F. Le, et al.. (1977). 2″- O -Phosphorylation of Gentamicin Components by a Staphylococcus aureus Strain Carrying a Plasmid. Antimicrobial Agents and Chemotherapy. 12(1). 26–30. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Michéa-Hamzehpour Breakdown of academic impact, for papers by A J Godfrey Breakdown of academic impact, for papers by Kiyomi Okamoto Breakdown of academic impact, for papers by A Yotsuji Breakdown of academic impact, for papers by B Kolek Breakdown of academic impact, for papers by L. D. Sabath Breakdown of academic impact, for papers by Kristen N. Schurek Breakdown of academic impact, for papers by Martin S. Linsell Breakdown of academic impact, for papers by Patrick Plésiat Breakdown of academic impact, for papers by KEIICHI SHIMIZU
Rankless by CCL
2026